Search

Inmode Ltd

Open

SectorGezondheidszorg

15.17 -1.11

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.96

Max

15.37

Belangrijke statistieken

By Trading Economics

Inkomsten

-15M

12M

Verkoop

-22M

82M

K/W

Sectorgemiddelde

11.37

68.51

EPS

0.25

Winstmarge

14.097

Werknemers

660

EBITDA

-17M

15M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+10.61% upside

Dividenden

By Acuity

Volgende Winsten

5 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-24M

882M

Vorige openingsprijs

16.28

Vorige sluitingsprijs

15.17

Nieuwssentiment

By Acuity

50%

50%

175 / 340 Rangschikking in Healthcare

Inmode Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 jul 2026, 18:56 UTC

Inmode Ltd shares are lower, influenced by declines in the Health Care Equipment sub-sector. The stock has traded lower since Wednesday's close.

29 jul 2026, 19:55 UTC

Inmode Ltd shares are lower Wednesday, continuing a decline since Tuesday's close amid broader market pressure from rising crude oil prices and inflation concerns.

28 jul 2026, 22:51 UTC

News

Inmode Ltd shares declined in after-market hours as Steel Partners urged shareholders to reject proposals, citing governance concerns and excessive compensation.

22 jul 2026, 19:16 UTC

Inmode Ltd shares are lower amid rising crude oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 jul 2026, 15:46 UTC

Inmode Ltd shares are lower Tuesday, extending a decline after three consecutive daily closes. The stock opened with a notable dip before recovering slightly.

20 jul 2026, 19:26 UTC

News

InMode Ltd faces scrutiny from Bronstein, Gewirtz & Grossman, LLC, over governance issues, contributing to a decline in its stock price since Friday's close.

Peer Vergelijking

Prijswijziging

Inmode Ltd Prognose

Koersdoel

By TipRanks

10.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 17 USD  10.61%

Hoogste 19 USD

Laagste 15 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Inmode Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

1

Buy

4

Hold

0

Sell

Sentiment

By Acuity

175 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
help-icon Live chat